NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) — all Canadian products
9 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02501430 | NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION | BAXTER CORPORATION | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.016 MG | Marketed | |
| 02501449 | NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION | BAXTER CORPORATION | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.032 MG | Marketed | |
| 02540630 | NOREPINEPHRINE BITARTRATE INJECTION | JUNO PHARMACEUTICALS CORP. | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Marketed | |
| 02538857 | NOREPINEPHRINE BITARTRATE INJECTION | AS KALCEKS | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Approved | |
| 00893285 | NOREPINEPHRINE BITARTRATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Marketed | |
| 02358743 | NOREPINEPHRINE BITARTRATE INJECTION, USP | STERIMAX INC | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Marketed | |
| 02241981 | LEVOPHED | PFIZER CANADA ULC | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Cancelled Post Market | |
| 02017679 | LEVOPHED LIQ IV 1.0MG/ML | SANOFI CANADA, INC. | Liquid | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Cancelled Post Market | |
| 02485680 | NOREPINEPHRINE BITARTRATE INJECTION USP | GENERIC MEDICAL PARTNERS INC | Solution | Intravenous | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG | Dormant |
Browse other molecules: